Patent ID: 7057059

Claim:
A compound of the general formula (I), wherein the substituents R 1 , R 1′ , R 2 , R 2′ , R 3 , R 3′ , R 4 , and R 4′ are independently selected from the group consisting of hydrogen, unsubstituted or substituted branched or unbranched alkyl, unsubstituted or substituted branched or unbranched alkenyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted cycloalkenyl, unsubstituted or substituted aryl and unsubstituted or substituted alkylaryl radicals, the substituents R 5 , R 5′ , R 6 , and R 6′ are independently selected from the group consisting of hydrogen, unsubstituted or substituted branched or unbranched alkyl, and unsubstituted or substituted branched or unbranched alkenyl radicals, and wherein optionally in each case at least two of the substituents R 1 , R 1′ , R 2 , R 2′ , R 3 , R 3′ , R 4 , and R 4′ can form with one another at least one unsubstituted or substituted alkylene, unsubstituted or substituted alkenylene radical or an unsubstituted or substituted aromatic ring, and wherein optionally at least one of the carbon atoms of the cyclohexane ring bearing the substituents R 1 , R 1′ , R 2 , R 2′ , R 3 , R 3′ , R 4 , and R 4′ is replaced by a heteroatom, and if the heteroatom is oxygen, the substituents R 1 , R 1′ , R 2 , R 2′ , R 3 , R 3′ , R 4 , and/or R 4′ can additionally be hydroxy radicals, and pharmaceutically compatible salts thereof, provided that at least one of the substituents R 1 , R 1′ , R 2 , R 2′ , R 3 , R 3′ , R 4 , or R 4′ is not equal to hydrogen and the radicals R 1 or R 1′ and R 4 or R 4′ do not form any unsubstituted C 1-2 -alkylene radicals with one another.